特殊STEMI-協(xié)和病例討論-楊明_第1頁
特殊STEMI-協(xié)和病例討論-楊明_第2頁
特殊STEMI-協(xié)和病例討論-楊明_第3頁
特殊STEMI-協(xié)和病例討論-楊明_第4頁
特殊STEMI-協(xié)和病例討論-楊明_第5頁
已閱讀5頁,還剩71頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

CaseSharing:

BrokenHeartSyndrome北京協(xié)和醫(yī)院

楊明病例1高某,女,67歲,病案號:C767493入院日期:2011-3-30主訴:

心悸、胸悶3h入院情況心電圖既往史

個人史、月經(jīng)婚育史、家族史無殊

入院查體

T36.8℃、HR117bpm、BP110/80mmHg,

SpO2100%(3L/min)

精神煩躁,時間及空間定向力準(zhǔn)確,對答切題,言語欠清,雙側(cè)瞳孔等大,對光反射靈敏,鼻膽管引流通暢、可見墨綠色膽汁、無異常臭味,心肺腹未見明顯異常,四肢肌力肌張力正常,雙側(cè)病理征及腦膜刺激征陰性。

入院診斷STEMI!

急診冠脈造影病例1冠脈造影病例1冠脈造影病例1冠脈造影病例1冠脈造影病例1冠脈造影心臟超聲(入院當(dāng)天3-30):心尖部心肌運(yùn)動明顯減弱,EF41%心臟超聲(入院當(dāng)天3-30):入院后治療可達(dá)龍艾司洛爾2d倍他樂克至今心肌酶變化表心電圖變化入院一周后一周后心臟超聲:

心尖部及左室余室壁運(yùn)動未見異常,EF73%

入院當(dāng)天一周后心臟超聲入院當(dāng)天一周后心臟超聲病例2韓某某,女,72歲

病案號1681545

主訴:胸悶10小時

入院日期:2010-11-30

入院情況胸痛時ECG

II,III,AVF,V2,V3,V4導(dǎo)聯(lián)ST段抬高我院急診搶救室(發(fā)病4h)

I,AVL,V2-4導(dǎo)聯(lián)ST抬高,V2呈QS型,V3rS型1:15pm(起病5h):我院急診查心肌酶:CK97U/l、CKMB9.5ug/l、cTnI2.51ug/l。

床旁UCG:室間隔中下段無運(yùn)動、心尖部、前壁運(yùn)動減低,EF單平面50%既往史:否認(rèn)高血壓、糖尿病、高血脂病史。個人史、月經(jīng)婚育史、家族史無特殊,不嗜煙酒。入院查體:HR100bpm,BP108/63mmHg,雙肺呼吸音低,雙下肺可及細(xì)濕羅音,左肺為著。心律齊,全腹韌,叩診實音,中下腹可及不規(guī)則包塊,質(zhì)韌,壓痛(+),無反跳痛、肌緊張,肝脾肋下未及,肝脾區(qū)無叩痛,移動性濁音(+),腸鳴音正常。雙下肢無水腫,雙足背動脈正常。左胸可見穿刺引流管通暢。入院診斷:冠狀動脈粥樣硬化性心臟病

急性ST段抬高性心肌梗死(前壁)心功能1級(Killip)盆腔占位卵巢癌可能性大雙側(cè)胸腔積液腹腔積液

STEMI!

病例2冠脈造影病例2冠脈造影病例2冠脈造影病例2冠脈造影病例2冠脈造影病例2冠脈造影病例2冠脈造影病例2冠脈造影診治經(jīng)過心肌酶發(fā)病12h達(dá)峰:cTnI4.87ug/l,CKMB28.1ug/l,CK239U/l,之后逐漸回落至正常床旁心臟超聲:室壁運(yùn)動及左室收縮功能逐漸恢復(fù)正常血脂:TC:3.57mmol/l,TG:1.24mmol/lLDL:1.83mmol/l,HDL:1.18mmol/l發(fā)病24h

I,AVLST段抬高,V2-4ST段抬高,V3R波恢復(fù)12月6日(發(fā)病7天)

V2-4T波雙向,R波恢復(fù)正常入院ECHO1周后ECHO入院ECHO1周后ECHO2個病例與常見的STEMI不同:STEMI?MyocardialinfarctionwithnormalcoronaryarteriesPathogeneticmechanisms正向重構(gòu)負(fù)向重構(gòu)IVUS纖維帽破口OCT能敏銳發(fā)現(xiàn)斑塊破裂OCTOCT能敏銳發(fā)現(xiàn)內(nèi)膜撕裂MisdiagnosesTako-tsubo-likesyndromeTako-tsubo-likesyndromeThisraresyndrome,?rstdescribedinJapanesepatientsin1991,consistsoftransientleftventriculardysfunctionwithchestsymptoms,electrocardiographicchangesandminimalmyocardialenzymereleasemimickingAMI,butwithoutsigni?cantCAD.stresscardiomyopathy“ampulla”cardiomyopathytransientleftventricularapicalballooningsyndrome“brokenheartsyndrome”neurogenicmyocardialstunning

In2006,underthename“stresscardiomyopathy”,itwasclassifiedwithinthegroupofacquiredcardiomyopathiesItwasnamedTako-tsubo-likesyndromebecauseoftheend-systolicshapeoftheleftventricleatventriculography,withapicalballooning,whichresemblesatako-tsubo,i.e.,theJapanesedeviceusedfortrappingoctopuses.EpidemiologyTheprevalenceofthediseaseisunknown.InJapanitisestimatedtobeashighas1-2%ofhospitaladmissionsforchestpainandacutedynamicST-segmentelectrocardiographicchanges.IntheUnitedStates

2-2.2%ofthepatientspresentingwiththeclinicalpictureofanST-segmentelevationacutemyocardialinfarction(STEMI)orunstableanginaareultimatelydiagnosedwithTTC.EpidemiologyStudiesinspecificpopulationshaveshownamuchhigherincidence.1/3ofthepatientstheystudied,whowereadmittedtoamedicalICUwithanon-cardiacdiagnosis(respiratoryfailureorsepsis),sufferedfromtransientleftventricularapicalballooning.AnincreasedincidenceofchronicobstructivepulmonarydiseaseorbronchialasthmawasfoundbyHerttingetalin32patientsdiagnosedretrospectivelywithTTC.Allthesefindingsoffersomeevidencesupportingthehypothesisthatcatecholaminesurgemayplayanimportantroleinthepathogenesisofthesyndrome.Triggeringconditions:psychologicaltrigger:unexpectedlossofacloserelative,confrontationwithanotherperson,devastatingfinancialloss,fearpriortoamedicalprocedure,etc.physicalstress

:pulmonarydisease,sepsis,trauma,cerebrovascularaccidentPathogenesisUnknownSeveraltheoriesCatecholaminesurgeoccultcoronaryatherosclerosiswithplaquerupturecoronaryspasmMicrovasculardysfunctionandspasmClinicalcharacteristicsChestpain(100%)ECG:56%ST-segmentelevation17%T-waveinversions10%Q-wavesorabnormalR-waveprogression.17%non-specificchangesornochangesatall.ECGdifferencearetoosubtletobehelpfulinthedifferentialdiagnosisbetweenTTCandanACSineverydayclinicalpractice.ThetimecourseoftheseECGchangesinTTCseemssimilartothatobservedinpatientswithearlyreperfusedST-elevationacutemyocardialinfarction,withT-waveinversionpersistingforatleast2-3weeksMinimallyelevatedcardiacmarkersCardiacimagingstudiesusuallyrevealextensiveapicaland/ormid-ventricularakinesisorhypokinesiswithbasalsparing,discordantwiththeminimallyincreasedcardiacenzymes.Thesewallmotionabnormalitiestypicallyextendbeyondthevascularterritoryofasinglecoronaryartery,suggestingthatmyocardialstunningratherthannecrosisistheunderlyingmechanismoftheacuteleftventriculardysfunction.冠脈造影Thetypicalfindingistheabsenceofobstructivecoronaryarterydisease.However,Ibanezetalwereabletodescribethepresenceofrupturedatheroscleroticplaquesinsomepatientswiththeuseofintravascularultrasound.Whetherthisfindingisofanypathophysiologicrelevanceremainscurrentlyunknown.左室造影MRITreatmentTheoptimaltreatmentforTTCremainsunknown.

Initialmanagementshouldbethetreatmentofmyocardialischemia(aspirin,clopidogrel,nitrates,intravenousheparinandβ-blockers)sendthepatientimmediatelytothecatheterizationlaboratoryClosemonitoringforthedevelopmentofheartfailure,cardiogenicshockormalignantarrhythmiasAfterthediagnosisofTTChasbeenestablished,antiplateletagentsandnitratesshouldbediscontinued.Ontheotherhand,sincethisiscatecholamine-inducedclinicalsyndrome,β-blockersshouldbekeptonboardandACEIshouldalsobestarteduntiltherecoveryofcardiacfunction.Diureticsareappropriateinthecasethatcongestiveheartfailuredevelops.Anticoagulationshouldalsobeconsideredinthecaseofseveresystolicdysfunctiontoreducetheriskofthromboembolism.PrognosisTTCusuallyhasabenigncoursewithfullrecoveryofleftventricularfunctionwithin2-4week

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論